Sight Diagnostics raises $71m to boost commercial operations
Israeli diagnostics company Sight Diagnostics has raised $71m in a Series D funding round to commercialise the global launch of finger-prick complete blood count (CBC) analyser.

Israeli diagnostics company Sight Diagnostics has raised $71m in a Series D funding round to commercialise the global launch of finger-prick complete blood count (CBC) analyser.
Abbott has received the US Food and Drug Administration (FDA) approval for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac…
Vapotherm is set to scale up capital equipment manufacturing capabilities to increase the production of its Precision Flow systems.
Brain-computer interface could translate thoughts into speech and US regulator sought additional details on $4.2bn Boston Scientific-BTG deal. Medicaldevice-network.com…
The US Food and Drug Administration (FDA) has approved two variants of Royal Philips’ 200mm and 150mm Stellarex 0.035”…
World-first cardio trial showed reduced wait times and hospital admissions and Orchestra gets CE-Mark for Moderato system to treat…
Varian will invest in privately held digital health company Oncora Medical to accelerate the development of precision medicine in…
iRhythm Technologies has collaborated with Alphabet’s health venture Verily to develop new technology for screening, diagnosing and managing atrial…
UK-based liquid biopsy company Angle has initiated the main phase of its ovarian cancer test study and enrolled its…
Thank you for subscribing to Medical Device Network